Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/101525
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: A longitudinal evaluation of performance of automated BCR-ABL1 quantitation using cartridge-based detection system
Author: Enjeti, A.
Granter, N.
Ashraf, A.
Fletcher, L.
Branford, S.
Rowlings, P.
Dooley, S.
Citation: Pathology, 2015; 47(6):570-574
Publisher: Elsevier
Issue Date: 2015
ISSN: 0031-3025
1465-3931
Statement of
Responsibility: 
Anoop Enjeti, Neil Granter, Asma Ashraf, Linda Fletcher, Susan Branford, Philip Rowlings, Susan Dooley
Abstract: An automated cartridge-based detection system (GeneXpert; Cepheid) is being widely adopted in low throughput laboratories for monitoring BCR-ABL1 transcript in chronic myelogenous leukaemia. This Australian study evaluated the longitudinal performance specific characteristics of the automated system.The automated cartridge-based system was compared prospectively with the manual qRT-PCR-based reference method at SA Pathology, Adelaide, over a period of 2.5 years. A conversion factor determination was followed by four re-validations. Peripheral blood samples (n = 129) with international scale (IS) values within detectable range were selected for assessment. The mean bias, proportion of results within specified fold difference (2-, 3- and 5-fold), the concordance rate of major molecular remission (MMR) and concordance across a range of IS values on paired samples were evaluated.The initial conversion factor for the automated system was determined as 0.43. Except for the second re-validation, where a negative bias of 1.9-fold was detected, all other biases fell within desirable limits. A cartridge-specific conversion factor and efficiency value was introduced and the conversion factor was confirmed to be stable in subsequent re-validation cycles. Concordance with the reference method/laboratory at >0.1-≤10 IS was 78.2% and at ≤0.001 was 80%, compared to 86.8% in the >0.01-≤0.1 IS range. The overall and MMR concordance were 85.7% and 94% respectively, for samples that fell within ± 5-fold of the reference laboratory value over the entire period of study.Conversion factor and performance specific characteristics for the automated system were longitudinally stable in the clinically relevant range, following introduction by the manufacturer of lot specific efficiency values.
Keywords: Automated quantitation; BCR-ABL1; chronic myelogenous leukemia; CML, monitoring; qRT-PCR
Rights: Copyright © 2015 Royal College of Pathologists of Australasia. All rights reserved. This is an openaccess article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. DOI: 10.1097/PAT.0000000000000293
RMID: 0030039093
DOI: 10.1097/PAT.0000000000000293
Appears in Collections:Pathology publications

Files in This Item:
File Description SizeFormat 
hdl_101525.pdfPublished version201.88 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.